BioSpace News Archive

Drug Development

Phase III Flop Ends Sanofi’s SERD Breast Cancer Candidate

All other ongoing and pending studies of Sanofi’s amcenestrant, including the early-stage breast cancer trial AMEERA-6, will also be discontinued.

August 17, 2022
·
3 min read
·
Tristan Manalac
Business

Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab

I-Mab quietly announced that its partner AbbVie is ending a Phase IB trial on lemzoparlimab for two types of cancers, despite a $2 billion deal inked in 2020.

August 17, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Positive Data Back Blueprint’s Bid for sNDA in Systemic Mastocytosis

Blueprint Medicines’ Ayvakit is headed to the FDA for a new indication after the drug hit the mark in Part 2 of the PIONEER trial for non-advanced systemic mastocytosis.

August 17, 2022
·
2 min read
·
Mark Terry
ScribeEMR Announces Remote Service Capability on More than 80 EMR Platforms Including the Top Five EMRs and Specialty Platforms

ScribeEMR, a leading provider of real-time remote medical scribe services, announces that it has surpassed its goal to provide remote scribe services on more than 80 EMR platforms, including the top three hospital EMRs and the top five EMRs used by outpatient practices.

August 17, 2022
·
3 min read
Business

Ambrx Announces Abrupt Leadership Change as Longtime Executive Tian Replaced

Kate Hermans has taken over the reins of Ambrx as interim CEO following the abrupt departure of Feng Tian.

August 17, 2022
·
3 min read
·
Alex Keown
Policy

In Historic Ruling, FDA Allows Sale of Over-the-Counter Hearing Aids

The FDA expects to foster innovation and competition among manufacturers, which would lower the prices of hearing aids without compromising their quality.

August 17, 2022
·
2 min read
·
Tristan Manalac
Business

Sanofi, Atomwise Ink Potential $1B+ R&D Deal

Atomwise inked a strategic research-and-development deal with Sanofi to use the AtomNet platform to identify and research up to five drug targets.

August 17, 2022
·
3 min read
·
Mark Terry
Drug Development

Newly Discovered Peptide could Prevent Seizures in Epilepsy, Alzheimer’s

Researchers recently developed a peptide called A1R-CT that could ultimately have therapeutic applications in both epilepsy and Alzheimer’s disease.

August 17, 2022
·
2 min read
·
Katherine Davis
Business

Kriya’s Rare Disease Division has a New Boss

Kriya Therapeutics tapped longtime pharma veteran Pedro Huertas as chief medical officer of its rare disease division.

August 17, 2022
·
2 min read
·
Alex Keown
Sacroiliac Fusion Implants Market: Increase in the Number of Skilled Orthopedic Surgeons to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Sacroiliac joints (SI) are joints between the sacrum and ilium bones of the pelvis.

August 17, 2022
·
6 min read